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Editor’s key points
† Brain tissue oxygenation
(Pbto2) and near-infrared
spectroscopy (NIRS)
parameters respond to
changes in arterial
pressure (AP) and
intracranial pressure
(ICP).
† NIRS and transcranial
Doppler (TCD) signals
react first to AP and ICP
changes. The reaction of
PbtO2 is delayed, revealing
that the analysed
modalities monitor
different stages of
cerebral oxygenation.
† In 77% of events tissue
oxygenation index (TOI)
and PbtO2 reacted in the
same direction.
Background. Brain tissue partial oxygen pressure (PbtO2) and near-infrared spectroscopy
(NIRS) are novel methods to evaluate cerebral oxygenation. We studied the response
patterns of PbtO2, NIRS, and cerebral blood flow velocity (CBFV) to changes in arterial
pressure (AP) and intracranial pressure (ICP).
Methods. Digital recordings of multimodal brain monitoring from 42 head-injured patients
were retrospectively analysed. Response latencies and patterns of PbtO2, NIRS-derived
parameters [tissue oxygenation index (TOI) and total haemoglobin index (THI)], and
CBFV reactions to fluctuations of AP and ICP were studied.
Results. One hundred and twenty-one events were identified. In reaction to alterations of
AP, ICP reacted first [4.3 s; inter-quartile range (IQR) 24.9 to 22.0 s, followed by NIRS-
derived parameters and CBFV (10.9 s; IQR: 25.9 to 39.6 s, 12.1 s; IQR: 23.0 to 49.1 s,
14.7 s; IQR: 28.8 to 52.3 s for THI, CBFV, and TOI, respectively), with PbtO2 reacting last
(39.6 s; IQR: 16.4 to 66.0 s). The differences in reaction time between NIRS parameters
and PbtO2 were significant (P,0.001). Similarly when reactions to ICP changes were
analysed, NIRS parameters preceded PbtO2 (7.1 s; IQR: 28.8 to 195.0 s, 18.1 s; IQR:
220.6 to 80.7 s, 22.9 s; IQR: 11.0 to 53.0 s for THI, TOI, and PbtO2, respectively). Two main
patterns of responses to AP changes were identified. With preserved cerebrovascular
reactivity, TOI and PbtO2 followed the direction of AP. With impaired cerebrovascular
reactivity, TOI and PbtO2 decreased while AP and ICP increased. In 77% of events, the
direction of TOI changes was concordant with PbtO2.
Conclusions. NIRS and transcranial Doppler signals reacted first to AP and ICP changes. The
reaction of PbtO2 is delayed. The results imply that the analysed modalities monitor different
stages of cerebral oxygenation.
Keywords: brain tissue partial oxygen pressure; cerebral haemodynamics; cerebral
oxygenation; cerebrovascular reactivity; near-infrared spectroscopy; tissue haemoglobin
index; tissue oxygenation index
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Adequate cerebral oxygen supply is fundamental to the man-
agement of patients after traumatic brain injury (TBI).1 – 4 Two
currently available methods of evaluating cerebral oxygen-
ation are direct brain tissue partial oxygen pressure (PbtO2 )
and near-infrared spectroscopy (NIRS). Monitoring of PbtO2 is
an invasive technique which has been used in a clinical
setting and has been shown to be related to outcome after
head injury.4 – 8 NIRS is a non-invasive method previously
used in fetal medicine and cardiac surgery,9 – 11 which has
not yet been widely accepted for routine clinical monitoring
in the adult neuro-intensive care setting.12 Traditionally,
NIRS uses the modified Beer–Lambert law to quantify the
concentration changes of oxygenated and deoxygenated
haemoglobin from an unknown baseline. The NIRS-derived
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parameters, which are currently being evaluated for monitor-
ing of the adult brain, are tissue oxygenation index (TOI) and
total haemoglobin index (THI).13 – 15 TOI and THI are calcu-
lated using spatially resolved spectroscopy, where a math-
ematical model based on the photon diffusion theory is
used to calculate the differential equation of light attenuation
with respect to distance from the source.16 The advantage of
spatially resolved spectroscopy is that the obtained par-
ameters are specific to the intracranial compartment17 and
that the obtained values are normalized and do not represent
changes from an unknown baseline. TOI is calculated as the
ratio of oxygenated haemoglobin and total tissue haemo-
globin, and it has been shown to be an index of cerebral
blood flow.10 16 18 – 20 THI, on the other hand, describes
changes in the total tissue haemoglobin level and has been
shown to represent blood volume.21 22 While in a recent
study, the response of PbtO2 to changes in arterial pressure
(AP) and intracranial pressure (ICP) have been described,23
little is known about the dynamic response patterns of NIRS
to different types of stimuli. Despite the similarities, PbtO2 and
NIRS are based on different physical processes and monitor
anatomically and physiologically different areas of the brain.
We hypothesize that these modalities monitor different
stages of cerebral oxygen supply and therefore will demonstrate
differences in the reaction times and the patterns of changes in
response to fluctuations of AP and ICP. The study aims to
observe and categorize the effect of haemodynamically rel-
evant events on cerebral perfusion and oxygenation as seen
by transcranial Doppler (TCD), NIRS, and invasive PbtO2
measurements. The knowledge of these response patterns
may aid in determining the level of oxygen supply insufficiency.
Methods
Multimodality brain monitoring was part of the standard clini-
cal protocol used to care for patients after TBI. Written consent
was obtained from patients or their next-of-kin to gather and
analyse data from all monitoring periods. The study was
approved by the institutional Research Ethics Committee.
Patients
Data obtained from 42 patients after closed head injury,
admitted to Neurosciences Critical Care Unit (NCCU) in
Addenbrooke’s Hospital, Cambridge, UK, from October 2008
to June 2009 were analysed.
Patients were managed according to an updated version
of a previously published ICP/cerebral perfusion pressure
(CPP)-oriented protocol where ICP was maintained below
20 mm Hg and CPP above 60–70 mm Hg.24 Reduction in
ICP was achieved with a stepwise escalation approach
by means of head positioning, analgesia, sedation, muscle
relaxation, moderate hyperventilation, ventriculostomy, use
of osmotic agents, and induced hypothermia. CPP was main-
tained with fluid expansion, vasopressors, and inotropes.
Intracranial hypertension refractory to medical management
was treated with either decompressive craniectomy or bar-
biturate coma. In patients with microdialysis and invasive
brain oxygenation monitoring, the target values were:
PbtO2.25 mm Hg and lactate–pyruvate ratio ,25. Ventilator
settings were titrated to maintain a PaCO2 level of 4.5–5.0 kPa
and a PaO2 of 13–15 kPa.
Monitoring and clinical data
Invasive monitoring included ICP (Codman ICP, MA, USA) and
PbtO2 (Licox, Integra Neurosciences Ltd, Hampshire, UK).
Monitoring probes were inserted into computed tomography
(CT)-normal parenchyma in the frontal area at a depth of
2.5 cm, via a triple access device (Technicam, Newton
Abbot, UK). Non-invasive monitoring included TOI and THI
measured with NIRO-200 (Hamamatsu Photonics UK Ltd,
UK) and cerebral blood flow velocity (CBFV) using a TCD
ultrasonograph (DWL Compumedics Ltd, Germany).
TOI and THI are measured using spatially resolved
spectroscopy. The method relies on the photon diffusion
theory.16 A photodiode emitting three wavelengths of light
within the near-infrared spectrum (775, 810, and 850 nm)
is coupled with a set of three photodiode detectors (with
1 mm separation). Equation (1) demonstrates the principal
of spatially resolved spectroscopy.16
∂A
∂r
= 1
ln 10
×
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√
+ 2
r
( )
(1)
Where A is attenuation, r the distance from light impulse
source, ma means absorption coefficient, and; ms′ the
reduced scatter coefficient.
The NIRO-200 measures ∂A/∂r at three wavelengths, there-
fore allowing the calculation of the coefficients of absorption
and scatter. Because the first-order approximation of the
scatter coefficient can be treated as a constant (k), the rela-
tive concentrations of oxygenated and deoxygenated haemo-
globin can be obtained (k*O2Hb and k*HHb, respectively).
16
TOI is calculated as O2Hb/O2Hb+HHb and it is expressed as
a percentage (%), while THI is calculated as O2Hb+HHb and
it is expressed as a relative value, representing a change
form the baseline, expressed in arbitrary units (a.u.).
All parameters were sampled at a frequency of 50 Hz. AP,
ICP, and PbtO2 were monitored continuously, and NIRS and
TCD monitoring were performed daily for periods of 15
and 1 h per day, respectively. All data were recorded synchro-
nously using ICM+ software (Cambridge Enterprise, Cam-
bridge, UK, http://www.neurosurg.cam.ac.uk/icmplus/). For
analysis, only the periods with all monitoring modalities
were used. Consequently, data available for analysis con-
sisted of 1 h of monitoring per patient, per day. Gas
exchange was assessed with arterial blood gas (ABG) analy-
sis during each of the monitoring sessions. Furthermore,
screening of patients’ medical notes was performed to ident-
ify any obvious respiratory pathology.
Recordings were stored digitally as a part of prospective
project managed by C.Z. oriented on the use of NIRS for
the assessment of autoregulation of blood flow in TBI
patients.15 Data were re-analysed retrospectively for the
purpose of this study.
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Data analysis
Data analysis was performed using ICM+ software (Cam-
bridge Enterprise, Cambridge, UK, http://www.neurosurg.cam
.ac.uk/icmplus/). Sampled signals of AP, ICP, CBFV, PbtO2 , TOI,
and THI were subject to manual artifact removal. Artifacts
which were excluded consisted of periods without a detectable
pulse waveform in the AP, ICP, or CBFV signals and rapid,
bimodal variations due to physiological stimulation of the
patient. All signals were treated with a moving-average filter
over 10 s.
Transient changes were defined as a ‘significant event’
when they constituted a sustained change lasting from 20 s
to 45 min, which was .5 mm Hg for ICP and 15 mm Hg for
AP. The PbtO2 , TOI, and THI responses were considered for
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Fig 1 Two AP-led events: (A) hypertensive and (B) hypotensive (black arrows demarcate onset of event). In both events, the direction of changes
of ICP is opposite to the direction of changes in AP, the initiating factor, demonstrating good cerebrovascular reactivity. A unidirectional change
of PbtO2 and TOI consistent with the variation of AP and CPP is visible: increase in (A) and decrease in (B). Changes of PbtO2 and TOI are also con-
sistent with the changes of CBFV. THI remains relatively stable during hypertensive events (A) while increases in hypotensive events (B), reflecting
presumably a vasodilatory effect leading to the observed, compensatory increase in ICP. AP trace in (A) depicts the method used to determine the
onset of an event. AP, arterial pressure; CBFV, cerebral blood flow velocity; CPP, cerebral perfusion pressure; ICP, intracranial pressure; THI, tissue
haemoglobin index; TOI, tissue oxygen index; PbtO2 , brain tissue partial oxygen pressure.
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analysis if PbtO2.4 mm Hg, TOI.1.5%, and THI.0.075 (a.u.),
and if they were clearly distinguishable from the surrounding
baseline variation.23 The time-point when a sustained
change in AP or ICP passed 10% of its maximum amplitude
was used as the onset of an event (Fig. 1A). In this way, the
analysis was oriented at observation of time delays between
changes of signals interpreted as an input (AP and ICP) and
the responses to these variations.
In the first instance, data were analysed for the presence
of significant events in AP and ICP. Secondly, we sought to
examine the alterations in PbtO2 , TOI, and THI that were
associated with these events. Thirdly, changes in CBFV
were examined. All identified events were subsequently
classified into groups depending on the triggering change
into either AP- or ICP-led. The latencies between the
onset of changes seen in AP or ICP and the subsequent
reactions of PbtO2 , TOI, THI, CBFV, and ICP (for AP-led
events) were calculated. Finally, the state of cerebrovascular
reactivity was examined. Cerebrovascular reactivity is one of
the mechanisms of cerebral autoregulation and it describes
the capacity of cerebral microcirculation to react to spon-
taneous changes in transmural pressure.25 It has been
shown that cerebrovascular reactivity can be assessed
using the pressure reactivity index (PRx).26 PRx was calcu-
lated as a Pearson’s correlation coefficient between thirty
consecutive 10 second averaged values of AP and ICP
using a 300 s moving window, as described previously.26
PRx ≥0.2 was chosen to be indicative of disturbed cerebro-
vascular reactivity.27 For events which lasted ,300 s (direct
calculation of PRx from that period was impossible), PRx
was calculated from a window beginning both immediately
prior and immediately after the event, so that the overall
duration was 300 s.
Statistical analysis
Data were not parametric. Friedman’s ANOVA was used to
determine the differences between multiple variables
within a group of events. Significance was set at P,0.05.
The Wilcoxon signed-rank test was used for comparing the
specific latencies between the triggering change (AP and
ICP) and reactions of PbtO2 , TOI, THI, and CBFV. The Bonfer-
roni correction for multiple comparisons was used with a sig-
nificance level set at P,0.007. The Mann–Whitney U-test
was used to compare the latencies between patients with
intact and impaired cerebrovascular reactivity. Correlations
between latencies and PRx were determined using
Spearman’s rank correlation coefficient.
Results
Forty-two patients fit the inclusion criteria. The mean age of
patients was 37 yr. On admission, there were 32 patients
with severe head injury [Glasgow Coma Scale (GCS) 3–8],
seven with moderate injury (GCS 9–12), and three with
mild injury (GCS 13–15). However, subsequently, all
patients required intensive care and mechanical ventilation.
Thirty-one patients (74%) had a diffuse type of injury
(Marshall grade 1–4), five (12%) had a mass lesion which
was evacuated (Marshall grade 5) while six (14%) had a
non-evacuated mass lesion (Marshall grade 6) (Table 1).
Table 1 Baseline characteristics of monitored patients. AP,
arterial pressure; ASDH, acute subdural haemorrhage; CBFV,
cerebral blood flow velocity; CPP, cerebral perfusion pressure; DAI,
diffuse axonal injury; DC, decompressive craniectomy; EDH,
epidural haemorrhage; EVD, external ventricular drainage; GCS,
Glasgow Coma Scale; ICP, intracranial pressure; IVH,
intraventricular haemorrhage; MAP, mean arterial pressure; NIRS,
near-infrared spectroscopy; PbtO2 , brain tissue partial oxygen
pressure; PCO2, partial pressure of arterial CO2; PO2, partial pressure
of arterial O2; SpO2 , arterial oxygen saturation; TCD, transcranial
Doppler; THI, tissue haemoglobin index; TOI, tissue oxygenation
index; tSAH, traumatic subarachnoid haemorrhage
N 42
Age [mean (SD), yr] 37 (19)
Sex (n)
Male 32
Female 10
Injury severity
Admission GCS (median, range) 8 (3–14)
GCS 3–8 (%) 32 (76)
GCS 9–12 (%) 7 (17)
GCS 13–15 (%) 3 (7)
Injury type (n)
DAI 7
Diffuse haemorrhagic contusions 18
Brain oedema w/o contusions 6
Focal mass lesion—non-evacuated 6
Evacuated mass lesion (ASDH, EDH) 5
IVH 3
tSAH 1
Treatment
Primary craniotomy 5
DC 2
EVD 3
Conservative 35
Monitoring time per session [mean (SD), min] 74.8 (21)
Number of cases with monitoring of modality (n)
AP 42
ICP 42
PbtO2 42
NIRS 42
TCD 30
Physiological parameters
PCO2 [mean (SD), kPa] 4.84 (0.65)
PO2 [mean (SD), kPa] 15.09 (2.86)
SpO2 (%) 98
MAP [mean (SD), mm Hg] 88 (9)
ICP [mean (SD), mm Hg] 17 (6)
CPP [mean (SD), mm Hg] 71 (9)
CBFV [mean (SD), cm s21] 67 (24)
PbtO2 [mean (SD), mm Hg] 24 (7)
TOI [mean (SD), %] 68 (5)
THI [mean (SD), a.u.] 0.99 (0.08)
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There were 105 monitoring sessions performed with a
median of 2 sessions per patient (range 1–8) on days 1–9
[median 2; inter-quartile range (IQR): 1–3] post-injury. The
mean duration of monitoring per session was 74.8 (21)
min. The mean ICP was 17 mm Hg, with a CPP of 71 mm
Hg and an MAP of 88 mm Hg. There were two patients
with CBFV .120 cm s21, suggesting traumatic vasospasm.
However, the Lindegaard ratio was ,3.0 and there was no
subarachnoid blood on the CT. There were no significant
differences in the monitored parameters (ICP, CPP, PbtO2 ,
TOI, THI, and FV) depending on the type of pathology
[diffuse axonal injury, diffuse haemorrhagic contusions/
brain oedema, focal mass lesion]. Although, there were no
significant differences in the absolute values of the moni-
tored variables between patients with hyper- and normocap-
nia, a moderate inverse correlation was found between TOI
and PCO2 (R¼20.44; P,0.05). When compared between
patients with impaired and intact cerebrovascular reactivity
(PRx ,0.2 indicated intact cerebrovascular reactivity), no sig-
nificant differences were found for the absolute values of the
monitored parameters.
One hundred and twenty-one transient events were ident-
ified. The observed patterns of changes are summarized in
Table 2, while the averaged time delays between the onset
of changes in the analysed parameters and the onset of
changes in AP are summarized in Table 3.
AP-led events (n596)
Two types of AP-led events were observed: hypotensive and
hypertensive (Fig. 1). Overall, the onset of ICP, PbtO2 , TOI,
CBFV, and THI changes was always delayed with respect to
AP. The shortest delay was seen for ICP—median 4.3 s
(IQR: 24.9 to 22.0 s), while the longest for PbtO2 —median
39.6 s (IQR: 16.4 to 66.0 s) (Table 3). The duration of latencies
was significantly different between signals (ANOVA P,0.001).
When compared between specific signals, the differences
in latencies of NIRS-derived indices and PbtO2 revealed stat-
istical significance (P,0.001). Furthermore, the difference in
latencies of ICP and PbtO2 was significant (P,0.001), while
that of ICP and NIRS-derived parameters was not. When
latencies were analysed separately for groups of events
occurring during intact and impaired cerebrovascular reactiv-
ity, no significant differences were observed (Table 3).
ICP-led events (n525)
There were 25 events triggered by an alteration in ICP. The
differences in the observed latencies showed statistical signifi-
cance (ANOVA P¼0.04; Table 3). When analysed separately, the
differences between latencies of NIRS-derived indices and
PbtO2 did reveal significant differences (P.0.05).
During ICP-led events, PbtO2 , TOI, and CBFV consistently
decreased while THI increased (Fig. 2).
Influence of cerebrovascular reactivity
on the response of oxygenation parameters
to changes in AP
Although no significant correlation between the latencies of all
analysed parameters and the state of cerebrovascular reactiv-
ity was observed, differences in the reaction patterns were
noted. In events occurring while the state of cerebrovascular
reactivity was intact (PRx ,0.2; n¼37), the changes in PbtO2
and TOI were concordant and followed the direction of AP
(Fig. 3A). In response to an increase in AP, THI remained
unchanged or changed only minimally (Fig. 3A), while in
response to a decrease in AP, THI increased (Fig. 1B).
In events occurring while cerebrovascular reactivity was
impaired (PRx ≥0.2; n¼59) three distinct patterns of PbtO2
and TOI responses have been identified. In the majority of
cases, changes in PbtO2 and TOI were concordant (n¼31);
however, in contrast to events with intact cerebrovascular
reactivity, PbtO2 and TOI decreased despite an increase in
AP and CBFV (Fig. 3B). There were 21 events where PbtO2
decreased while TOI increased and seven where PbtO2
increased while TOI decreased in response to increasing AP
and CBFV (Fig. 3C and D). Overall, in 71% of AP-led events
and in 77% of all events, the direction of changes of TOI
was concordant with the direction of changes of PbtO2 .
The post hoc power calculation revealed that the study
was not sufficiently powered to detect significant differences
between latencies; therefore, the presented results may be
prone to type II error.
Table 2 Classification of events and characterization of responses in relation to the triggering parameter. AP, arterial pressure; CBFV, cerebral
blood flow velocity; ICP, intracranial pressure; PbtO2 , brain tissue partial oxygen pressure; PRx, pressure reactivity index; THI, tissue haemoglobin
index; TOI, tissue oxygen index; +, a change in the same direction as the direction of changes of the triggering parameter; 2, a change in the
opposite direction to the direction of changes of the triggering parameter
Event type Triggering parameter Cerebrovascular reactivity Direction of changes in relation to triggering parameter
ICP PbtO2 TOI THI CBFV
AP-led (n¼96) AP change Intact (PRx ,0.2) (n¼37) 2 + + No change +
Impaired (PRx ≥0.2) (n¼59) + 2 2 + +
+ 2
2 +
ICP-led (n¼25) ICP change Impaired (PRx ≥0.2) N/A 2 2 + 2
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Discussion
Our results show that PbtO2 , TOI, and THI (monitored with
NIRS) respond to changes in AP and ICP and that the direc-
tion of changes of TOI is concordant to that of PbtO2 in
77% of the analysed events. However, the differences in
latencies between the modalities suggest that PbtO2 and
NIRS monitor different stages of cerebral oxygen supply.
Time delays between modalities
A stereotyped temporal sequence of responses was observed
in all events, regardless of the initiating factor. Overall,
changes in ICP were the earliest consequences of AP
increases, occurring with a median delay of ,5 s. The reac-
tion time of THI and TOI, just over 10 and 14 s, respectively,
was comparable with that of CBFV. However, the sequence of
events is suggestive of THI being more susceptible to blood
volume changes, with an early reaction visible before
changes in CBFV. TOI, on the other hand, demonstrates a
delayed reaction (visible after changes in CBFV) indicating
an influence of oxygenation changes secondary to modifi-
cation of cerebral blood flow. This assumption is further sup-
ported by the observed differences in patterns of THI
changes during events with intact and impaired cerebrovas-
cular reactivity. In the first case, only small changes are seen
in THI, typically opposite to changes in AP, while during
impaired cerebrovascular reactivity, THI changes follow
those of AP (similarly to changes in ICP, which are represen-
tative of vascular dilation and blood volume changes).
In contrast, changes in PbtO2 were visible last and typically
delayed by almost 40 s (Table 3), suggesting that local tissue
stores of oxygen buffered the changes in oxygen delivery.
The observed sequence of events supports the assump-
tion that AP and ICP fluctuations exert changes which
spread from the proximal, large arteries, through the micro-
vascular compartment to the parenchyma.
Effects of AP changes on PbtO2, TOI, and THI
We have demonstrated that both TOI and PbtO2 follow AP
changes, while THI changes in the opposite direction. These
results differ from previous work describing the relationship
of PbtO2 and spontaneous fluctuations in AP.
28 It has been
shown that PbtO2 passively follows changes in AP only
during impaired cerebrovascular reactivity, which formed
the basis behind the autoregulatory index ORx.28 However,
the averaging period used when calculating ORx was 1 h,
while in our study, the median duration of the analysed
events was 431 s. We hypothesize that the events studied
here may have been too short to reflect the autoregulatory
mechanisms involved in oxygen delivery.
When analysing events which occurred during impaired
cerebrovascular reactivity, we have observed opposite
reactions of PbtO2 and TOI (Fig. 3). Equation (2), which was
proposed by Tachtsidis and colleagues,29 provides a possible
explanation for the relationship between TOI and blood
oxygen saturation, CBF, cerebral oxygen metabolism, and
cerebral blood volume (CBV). It is, therefore, possible that
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Fig 2 Two ICP-led events during a single recording from one patient (black arrows). An increase in ICP is the initiating factor and results in a
decrease in CPP. PbtO2 and TOI decrease, mirroring the changes of CPP. The decrease in CBFV is a reflection of the dilated microvascular bed
and is accompanied by an increase in THI, reflecting an increase in CBV. AP, arterial pressure; CBFV, cerebral blood flow velocity; CPP, cerebral
perfusion pressure; ICP, intracranial pressure; THI, tissue haemoglobin index; TOI, tissue oxygen index; PbtO2 , brain tissue partial oxygen pressure.
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Fig 3 Example of four AP-led events during intact (A) and impaired cerebrovascular reactivity (B–D). All events represent an increase in AP
(black arrows demarcate the onset of stimulus); however, in (A), it is accompanied by a decrease in ICP while in (B), (C), and (D) by an increase
in ICP, representing passive pressure–volume transmission. Different patterns of responses of PbtO2 and TOI are seen: (A) both PbtO2 and TOI
increase; (B) both PbtO2 and TOI decrease; (C) PbtO2 decreases while TOI increases; and (D) PbtO2 increases while TOI decreases. In all events,
CBFV follows the changes in AP, but the reaction is more pronounced in (B), (C), and (D). No change in THI is seen in (A), while an increase is seen
in (B) and (C) representing increased CBV and a decrease in (D) representing decreased CBV. AP, arterial pressure; CBFV, cerebral blood flow
velocity; CBV, cerebral blood volume; CPP, cerebral perfusion pressure; ICP, intracranial pressure; THI, tissue haemoglobin index; TOI, tissue
oxygen index; PbtO2 , brain tissue partial oxygen pressure.
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as a result of increased AP, blood is passively pushed into the
dilated cerebral microvasculature increasing CBV, resulting in
a relative increase in oxygenated haemoglobin and in conse-
quence an increase in TOI. This is also supported by the
observed increase in THI, representing increased CBV. Vasodi-
latation in such cases would not be reflected by PbtO2
measurements where free, diffused oxygen is measured.30
TOI = SaO2 −
CBVven
CBVven + CBVart
( )
× CMRO2
k× CBF × [Hb × 10−2]
( )
× 100% (2)
Where TOI is the tissue oxygenation index, SaO2 the arterial
blood oxygen saturation, CBVven the venous CBV, CBVart the
arterial CBV, CMRO2 the cerebral metabolic rate of oxygen,
k the oxygen combining power of haemoglobin, CBF the
cerebral blood flow, and Hb the haemoglobin SaO2 .
Effects of ICP changes on PbtO2, TOI, and THI
During ICP-led events, predominantly plateau waves, both
PbtO2 and TOI decreased and remained decreased for the
whole duration of the wave. Plateau waves are thought to
be a result of a vascular dilatory cascade, leading to an
increase in CBV with a corresponding decrease in CBFV and
CPP.31 – 33 The observed decreases in PbtO2 and TOI during
these events are presumably a consequence of the decreases
in cerebral perfusion, resulting in a decrease in oxygen
supply. The observed decreases in cerebral oxygenation for
the whole duration of the wave support the need for rapid
interventions lowering ICP in such situations.34
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Limitations
There are several limitations to our study. First, the retrospec-
tive nature of the analysis does not allow concluding causal-
ity between the trigger events (AP and ICP changes) and the
reactions of the oxygenation parameters. Although, it is likely
that changes in AP and ICP influenced cerebral oxygenation,
it is also plausible that a third factor was responsible for both
the haemodynamic, ICP, and oxygenation changes. Further-
more, the relationship of the location of PbtO2 and NIRS
probes with regard to the site of injury was not considered.
However, we believe that assessment of the temporal
profile of the observed changes, which was the aim of the
study, should not have been altered by the location of the
probes. We were also unable to retrieve exact information
regarding the ventilator setting of the monitored patients.
We acknowledge that it is potentially erroneous to draw
definitive conclusions from cerebral oxygenation monitoring
without precise knowledge of oxygenation and gas
exchange. However, the obtained ABG analyses, although
not continuous, demonstrate the absence of respiratory
failure/insufficiency during the monitoring period. We have
used the PRx for assessment of cerebrovascular reactivity.
Although, the methodology of calculating PRx26 includes
AP, we do not think this precludes its use in analysing
response patterns to AP changes. PRx relies on spontaneous
fluctuations of AP (frequency of 0.3–3 beats min21) and it
does not take into account the large-scale changes that
are the subject of this study.
In all cases, the earliest reaction to changes in AP and ICP
was seen in THI and CBFV followed by TOI, with changes in
PbtO2 visible last, implying that all modalities monitor different
stages of supplying oxygen to the brain. Therefore, we conclude
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that PbtO2 and NIRS are complementary methods which should
be analysed with respect to other intracranial parameters. Both
methods show complex interrelationships with other haemo-
dynamic determinants. The observed results suggest that mul-
timodal brain monitoring can be used to evaluate the different
stages of cerebral oxygen supply.
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